Switzerland IEEPA Tariff Refund Recovery
Recover IEEPA Duties Paid on Swiss Imports
Switzerland sends the United States some of its highest per-entry import values globally — branded pharmaceuticals, biologics, precision medical devices, luxury watches, and industrial instruments. IEEPA tariffs on every Swiss-origin entry have been ordered refunded. CAPE Phase 3 is live as of October 6, 2026.
$134.7B
Accepted for Processing
Phase 3
Now Live — Oct 6, 2026
Get Free Assessment
How CAPE Works
Switzerland: Pharma, Watches, and Precision Instruments
Switzerland is a top-ten U.S. import source by value, and its export profile is uniquely concentrated in high-value, low-volume categories. Novartis, Roche, and Lonza ship finished pharmaceuticals and biologics that routinely generate the highest per-entry IEEPA duty figures of any European exporter. Alongside pharma, Swiss exports include luxury and precision watches (Rolex, Swatch Group, Richemont brands), precision surgical instruments and medical devices (Straumann, Sonova, Hamilton Medical), specialty chemicals, and high-end machinery. IEEPA tariffs applied across all these categories, and the Federal Circuit has ordered them refunded.
The defining challenge for Switzerland CAPE claims is related-party transfer pricing. The majority of Swiss pharmaceutical imports enter through U.S. affiliates of Swiss parent companies, with intercompany pricing subject to IRS and CBP scrutiny. The IEEPA duty refund basis must be computed from the correct dutiable value, which requires careful review of the original entry documentation and any First Sale elections.
Top Import Categories from Switzerland Affected
- Branded pharmaceuticals and biologics — oncology, immunology, cardiovascular (HTS Chapter 30)
- Active pharmaceutical ingredients and chemical intermediates (HTS Chapter 29)
- Luxury and precision watches and movements (HTS Chapter 91)
- Precision surgical instruments, implants, and medical devices (HTS Chapter 90)
- Specialty chemicals, dyes, and pigments (HTS Chapter 28)
- Industrial measurement and control instruments (HTS Chapter 90)
- High-precision CNC machinery and tooling (HTS Chapter 84)
- Specialty food products — chocolate, dairy, confectionery (HTS Chapters 18–19)
Key Issues for Switzerland Importers
Related-Party Transfer Pricing
Most Swiss pharmaceutical entries involve related-party transactions between Swiss parent companies and U.S. affiliates. Dutiable value in these entries may reflect intercompany pricing that requires reconciliation against arm’s-length benchmarks. We review original declared values and First Sale elections to establish the correct IEEPA refund basis under CAPE.
Watch and Instrument Valuation
High-value Swiss watch imports — particularly luxury mechanical movements and completed watches — carry large per-unit IEEPA duty figures. Entries with complex assembly chains (movements from one source, cases from another, assembly in Switzerland) require HTS classification review to confirm country-of-origin and the correct CAPE refund amount.
Biologics and Specialty Drug Classification
Biologic drugs (monoclonal antibodies, cell therapies, recombinant proteins) shipped from Swiss manufacturing facilities may classify under different HTS headings than small-molecule pharmaceuticals. Classification at the Chapter 29/30 boundary directly determines the applicable IEEPA rate and the CAPE refund amount. We audit classification before filing.
Our Switzerland Refund Recovery Process
Step 1: Pharma and High-Value Entry Audit
We compile all Swiss-origin entry summaries, prioritizing pharmaceutical and biologic entries by IEEPA duty exposure. We review declared values, First Sale elections, and related-party pricing documentation to confirm the correct duty basis for each entry.
Step 2: Classification and Valuation Review
Watch and instrument entries are reviewed for HTS classification accuracy and country-of-origin documentation. Biologics are audited for correct classification at the Chapter 29/30 boundary. Every entry cleared through this review is packaged for CAPE Phase 3 submission.
Step 3: CAPE Filing and Disbursement
All filings are coordinated with or executed through a licensed customs broker in accordance with 19 C.F.R. Part 111. We prepare the complete CAPE submission package for each eligible entry and manage all CBP correspondence through final disbursement.
Advisory only — not legal advice. Customs brokerage services are coordinated with or executed through a licensed customs broker in accordance with 19 C.F.R. Part 111. The Tariff Bureau LLC is not itself a licensed customs broker. Governing law: Georgia. Arbitration: Fulton County, GA.
Recover What You’re Owed on Swiss Imports
IEEPA tariffs on Swiss pharmaceuticals, watches, and precision instruments have been ordered refunded. CAPE Phase 3 is live — act before CBP processing windows close.
Free Assessment
Learn More